About the journal
Melanoma Management is an open-access journal published by Taylor & Francis Group in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 1,415 USD. Declared review time at DOAJ: 13 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Taylor & Francis Group
- ISSN
- 2045-0885 · 2045-0893
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,415 USD
- Articles in DOAJ
- 86
- Declared review time
- 13 weeks
- Declared peer-review model
- double_blind
- Official website
- https://www.tandfonline.com/journals/immt20
Index listings
- DOAJ · 2019-03-11
- PUBMED · 2015-01-01
- Indexing
- DOAJ · PUBMED
- APC
- 1,415 USD
- Declared review time (DOAJ)
- 13 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
86
Most recent article
8 months ago
Average review time (journal-declared via DOAJ)
13weeks
Works in OpenAlex
220
Last recorded publication year
2025
h-index
25
i10-index
67
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2024-08-08
- Added to DOAJ
- 2019-03-11
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 36%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101649842
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cutaneous Melanoma Detection and Management
- Cutaneous Melanoma Detection and Management
- Melanoma and MAPK Pathways
- Melanoma and MAPK Pathways
- CAR-T cell therapy research
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
Show all subjects (50)
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Nonmelanoma Skin Cancer Studies
- Nonmelanoma Skin Cancer Studies
- Skin Protection and Aging
- Skin Protection and Aging
- Ocular Oncology and Treatments
- Ocular Oncology and Treatments
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cell Image Analysis Techniques
- Computational Drug Discovery Methods
- Cell Image Analysis Techniques
- Computational Drug Discovery Methods
- melanin and skin pigmentation
- melanin and skin pigmentation
- AI in cancer detection
- Brain Metastases and Treatment
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- AI in cancer detection
- Brain Metastases and Treatment
- HER2/EGFR in Cancer Research
- Optical Coherence Tomography Applications
- Optical Coherence Tomography Applications
- Cutaneous lymphoproliferative disorders research
- HER2/EGFR in Cancer Research
- Cutaneous lymphoproliferative disorders research
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Microbial Inactivation Methods
- Cancer Mechanisms and Therapy
- Cancer Mechanisms and Therapy
- Protein Degradation and Inhibitors
- Cancer survivorship and care
- Cellular Mechanics and Interactions
- Cancer survivorship and care
- Cellular Mechanics and Interactions
- Microbial Inactivation Methods
- Protein Degradation and Inhibitors
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
Keywords (DOAJ)
- melanoma
- skin cancer
- metastasis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ